Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

HPV vaccine development after more than ten years approval

View through CrossRef
At present, ten years have passed since the human papillomavirus (HPV) vaccine was first approved for use in humans. Research related to HPV vaccine, both in terms of effectiveness and immugenicity in its development, has been widely carried out, such as in terms of the indications of the HPV vaccine use that is not only for preventing cervical cancer, the guidelines for administering 2-dose HPV vaccines for those under 15 years of age, and the discovery of the latest HPV vaccine types: nonavalent HPV vaccine. This review literature discusses all aspects of the development of HPV vaccine since it was first approved for use in humans in 2006.
Title: HPV vaccine development after more than ten years approval
Description:
At present, ten years have passed since the human papillomavirus (HPV) vaccine was first approved for use in humans.
Research related to HPV vaccine, both in terms of effectiveness and immugenicity in its development, has been widely carried out, such as in terms of the indications of the HPV vaccine use that is not only for preventing cervical cancer, the guidelines for administering 2-dose HPV vaccines for those under 15 years of age, and the discovery of the latest HPV vaccine types: nonavalent HPV vaccine.
This review literature discusses all aspects of the development of HPV vaccine since it was first approved for use in humans in 2006.

Related Results

Trajectories of and spatial variations in HPV vaccine discussions on Weibo, 2018-2023: a deep learning analysis
Trajectories of and spatial variations in HPV vaccine discussions on Weibo, 2018-2023: a deep learning analysis
SummaryResearch in contextEvidence before this studyWe first searched PubMed for articles published until November 2023 with the keywords “(“HPV”) AND (“Vaccine” or “Vaccination”) ...
High rate of non-vaccine targeted high-risk HPV genotypes circulate among women in Eastern Ethiopia
High rate of non-vaccine targeted high-risk HPV genotypes circulate among women in Eastern Ethiopia
AbstractThe World Health Organization [WHO] recommends a genotype-specific human papillomavirus [HPV] vaccination as a primary prevention strategy to control the burden of cervical...
Abstract PR01: HPV structure and functional alterations impact prognosis in HPV (+) oropharyngeal squamous cell carcinoma
Abstract PR01: HPV structure and functional alterations impact prognosis in HPV (+) oropharyngeal squamous cell carcinoma
Abstract Background: Over the last two decades, there has been a sharp increase in the incidence of oropharyngeal squamous cell carcinoma (OPSCC) linked to human pap...
Facilitating factors and barriers for intention to accept HPV vaccine among young females in Hanoi - Viet Nam
Facilitating factors and barriers for intention to accept HPV vaccine among young females in Hanoi - Viet Nam
The objectives of the study were to assess facilitating factors and barriers for intention to get HPV vaccine among 15-25 years old females in Hanoi, Vietnam based on Health Belief...
Predicting prognosis in oral and oropharyngeal cancer
Predicting prognosis in oral and oropharyngeal cancer
The aim of this thesis was to better predict prognosis in oral and oropharyngeal cancer. HPV-positive oropharyngeal cancers have a more favorable prognosis than HPV-negative OPSC...

Back to Top